Armistice Capital’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Armistice Capital’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-860,000	Closed	-$2.31M	–	109
2018 Q3	$2.31M	Hold	860,000	–	–	0.14%	68
2018 Q2	$3.84M	Hold	860,000	–	–	0.25%	62
2018 Q1	$4.89M	Buy	860,000 +666,400	+344%	+$4.82M	0.37%	53
2017 Q4	$1.55M	Buy	+193,600	New	+$1.76M	0.15%	59

Other funds holding IPCI

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Armistice Capital's IPCI Position: Q4 2018 in Review

Armistice Capital sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2018, closing a stake of 860,000 shares — an estimated $2.31M sold.

Armistice Capital first reported a position in IPCI in Q4 2017 and held it in 4 quarters. The position peaked at $4.89M in Q1 2018. 12 funds tracked by Wall St. Rank hold IPCI as of Q4 2018.

Armistice Capital reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2018 after selling out during the quarter.
Armistice Capital sold 860,000 Intellipharmaceuticals International Inc. shares in Q4 2018, an estimated $2.31M.
Armistice Capital first reported a position in Intellipharmaceuticals International Inc. in Q4 2017 and held it in 4 quarters.
Armistice Capital's Intellipharmaceuticals International Inc. position peaked at $4.89M in Q1 2018.
12 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2018.

Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.